Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • Ukraine
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
    • COVID-19
  • Features
    • How-to
    • Knowledge & Insights
    • Guest Contributions
  • Partners
    • Amsterdam
    • Rise by Techleap.nl
    • Fintech Files by AWS
    • Scaling-up in Europe
    • Blue Tulip Awards
    • Partner with us
    • Promoted content
  • Jobs
  • About us
    • Partner with us
    • About
    • Team
    • Newsletter
  • Contact
  • Home
  • News
    • Ukraine
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
    • COVID-19
  • Features
    • How-to
    • Knowledge & Insights
    • Guest Contributions
  • Partners
    • Amsterdam
    • Rise by Techleap.nl
    • Fintech Files by AWS
    • Scaling-up in Europe
    • Blue Tulip Awards
    • Partner with us
    • Promoted content
  • Jobs
  • About us
    • Partner with us
    • About
    • Team
    • Newsletter
  • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

Medopad rebrands to Huma, acquires two UK tech companies & appoints former UK Health Minister as Chairman

Shubham Sharma by Shubham Sharma
April 16, 2020
in News, Health & Medtech, Startups
Medopad rebrands to Huma, acquires two UK tech companies & appoints former UK Health Minister as Chairman
60
SHARES
LinkedInTwitterWhatsAppFacebook

Here at Silicon Canals, we have extensively covered the factors contributing to the success of a startup. While most people believe that the idea is the most crucial factor, there’s survey data that indicates otherwise. One startup that did rather well and caught everyone’s attention early on is Medopad. The UK-based healthtech company has raised over $50 million (€46 million approx.) till date and now, it has made some new announcements. 

Medopad rebrands to Huma

The UK-based healthtech startup is now rebranding to Huma. The company believes that this rebranding is impertinent for reflecting its commitment and mission as its services now go beyond remote patient monitoring and into digital biomarkers and therapeutics. The company was founded in 2011 by Dan Vahdat and Rich Khatib. Partnering with scientists, healthcare and pharmaceutical professionals, and technologists, the company builds proactive healthcare solutions via a portfolio of DTx and digital biomarkers. 

- Partner content -
EIT Digital
EIT Digital Challenge 2022 is here!
Calling all European deep-tech scaleups for EIT Digital Challenge 2022Show More
Calling all European deep-tech scaleups for EIT Digital Challenge 2022 Show Less
Read more

Dan Vahdat, founder and CEO of Huma, commented, “We’ve been through quite a journey since Medopad started in 2011. Medopad has specialised in remote patient monitoring for patients with rare and chronic diseases. Over time, we’ve realised that health is about more than disease states; it’s about general physical and mental wellbeing go hand-in-hand. That’s why it makes perfect sense for us to evolve what the company stands for, what we offer, and why we do what we do. That’s why from today, Medopad is now Huma. Huma reflects our commitment to working with people, for people. The name Huma says that we’re for all of humanity.”

Huma appoints former UK Health Minister as chairman of its board of directors

Huma has also appointed the former UK Secretary of State for Health The Right Honourable Alan Milburn as chairman of the Huma board of directors. Mr Milburn served as a Member of Parliament for Darlington from 1992 until 2010, including serving as Health Secretary from 1999 until 2003. After working with the government, he took up roles such as Chairman of the European Advisory Board at Bridgepoint Capital and Chair of PwC’s UK Health Industry Oversight Board. PricewaterhouseCoopers (PwC). He also serves as Chancellor of Lancaster University.

The Right Honourable Alan Milburn, Chairman of the Huma Board of Directors, says, “I’m pleased to work with Huma to help transform the health sector by developing a new understanding of the human body through digital biomarkers. We’re at the very early stages of what could be breakthroughs in how we understand health, diagnose and treat illnesses and Huma could become a true leader in this promising new area for life sciences, innovation partners and healthcare.”

Huma acquires BioBeats and Tarilian Laser Technologies (TLT)

Further, Huma has also acquired a couple of UK based tech companies to further its mission and development. The company has acquired  AI and wearable technology businesses, BioBeats and Tarilian Laser Technologies (TLT). 

Biobeats is a London-based company that aims to be the pioneer of preventative mental health by developing clinically-validated products. These products are able to predict, diagnose and treat mental health disorders. The company’s flagship product, BioBase is a mobile app that is paired with biosensors and a wearable device. It collects biometric data, such as heart rate variability, and psychometric measures (e.g. mood journaling) to deliver a personalised wellbeing score for the users. 

David Plans, BioBeats co-founder and CEO says, “We share a vision with Huma for pioneering preventative health. We want people to go from simply surviving to thriving. By creating clinically-validated products to predict, diagnose and treat mental health disorders, we allow everyone to flourish. We are excited to join Huma to realise our ambition for preventative mental health and wellbeing to people around the world. With Huma’s experience, global partners and innovation capabilities, we look forward to joining the Huma team to help people live longer, fuller lives.”

TLT is a Hertfordshire-based medical technology company. It has come up with an unobtrusive wearable device that sits on a person’s wrist and it is believed to be an innovative breakthrough in blood pressure monitoring. This new sensor employs light modulation to detect motion, including continuous beat-by-beat flow motion forces that determine arterial blood pressure. Thus, this new, clinically-validated technology, is able to relay continuous blood pressure monitoring without a cuff. 

Stay tuned to Silicon Canals for more European technology news

 - Partner content -
How cybersecurity scaleup Intigriti conquered the world?
How cybersecurity scaleup Intigriti conquered the world?
Catch our interview with Paul Down, Head of Sales at Intigriti.
Catch our interview with Paul Down, Head of Sales at Intigriti. Show Less
Read more
Tags: Health-& Medtech
Share4Tweet14SendShare28

Partner content | Work with us

Tokenisation is the future of the financial services industry, and Luxembourg’s Tokeny is at the helm of this change

Copilot for growers: Source.ag’s Rien Kamman explains how it helps growers increase their fresh produce with AI

Waste problem is complex, but Seenons has a solution: CEO and co-founder Joost Kamermans explains the plan

Want to scale your business in Germany and Europe? Here’s how the Scaleup Landing Pad Hamburg can help

Is your deep tech scaleup aiming high? The EIT Digital Challenge 2022 can get you there

Silicon Canals | Jobs


Breaking news from Amsterdam | Partner

Founders on funding: Greener Power Solutions’ founders on their effort to reduce CO2 footprint and raising funds to support it

Founder in Residence: Slimmer AI’s Daniela Redondo Vélez on how it aims to help founders early in their dream to build new age B2B AI solutions

Amsterdam and Paris-based Trezy bags €1M, opens European headquarters in the Dutch capital

Amsterdam’s Just Eat Takeaway made progress towards profitability in H1 2022: Report

Advertisement

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2022 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • Ukraine
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
    • COVID-19
  • Features
    • How-to
    • Knowledge & Insights
    • Guest Contributions
  • Partners
    • Amsterdam
    • Rise by Techleap.nl
    • Fintech Files by AWS
    • Scaling-up in Europe
    • Blue Tulip Awards
    • Partner with us
    • Promoted content
  • Jobs
  • About us
    • Partner with us
    • About
    • Team
    • Newsletter
  • Contact

Silicon Canals 2014-2022 | Website: Bright Idiots

Stay updated with the Silicon Canals daily and weekly newsletters.
We promise we won't spam you. You can choose to unsubscribe anytime.
Stay updated with the Silicon Canals daily and weekly newsletters.
We promise we won't spam you. You can choose to unsubscribe anytime.
Silicon Canals
Manage your privacy

To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Statistics

Marketing

Features
Always active

Always active
Manage options Manage services Manage vendors Read more about these purposes
Manage options
{title} {title} {title}
X
X